Auristatin E CAS:160800-57-7, a highly potent cytotoxic molecule derived, disrupts microtubule dynamics in cancer cells, inducing apoptosis. With its unique structure, it has become a critical component in the development of antibody-drug conjugates (ADCs), revolutionizing targeted cancer therapies by selectively delivering the cytotoxic agent to tumor cells while sparing healthy tissues, thereby enhancing treatment efficacy and minimizing adverse side effects in oncology applications.
AxisPharm offers 5000+ PEG Linkers with high purity. Different kinds of PEG Reagents may be available by custom synthesis.